Yeon Ju Kyung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yeon Ju Kyung has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Craig B. Thompson
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, USA
22 shared publications - Agata A. Bielska
AstraZeneca, Waltham, USA
21 shared publications - Caitlin F. Harrigan
Department of Computer Science, University of Toronto, Toronto, Canada
21 shared publications Quaid Morris
21 shared publications- Wilhelm Palm
Division of Cell Signaling and Metabolism, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany
21 shared publications - Jiajun Zhu
State Key Laboratory of Molecular Oncology, School of Basic Medical Sciences, Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
The mTOR is a key regulator of cell growth that integrates growth factor signaling and nutrient availability and is a downstream effector of oncogenic receptor tyrosine kinases (RTK) and PI3K/Akt signaling. Thus, activating mTOR mutations would be expected to enhance growth in many tumor types. However, tumor sequencing data have shown that mTOR mutations are enriched only in renal clear cell carcinoma, a clinically hypervascular tumor unlikely to be constrained by nutrient availability. To further define this cancer-type–specific restriction, we studied activating mutations in mTOR. All mTOR mutants tested enhanced growth in a cell-type agnostic manner under nutrient-replete conditions but were detrimental to cell survival in nutrient-poor conditions. Consistently, analysis of tumor data demonstrated that oncogenic mutations in the nutrient-sensing arm of the mTOR pathway display a similar phenotype and were exceedingly rare in human cancers of all types. Together, these data suggest that maintaining the ability to turn off mTOR signaling in response to changing nutrient availability is retained in most naturally occurring tumors.Significance:This study suggests that cells need to inactivate mTOR to survive nutrient stress, which could explain the rarity of mTOR mutations and the limited clinical activity of mTOR inhibitors in cancer.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
The mTOR is a key regulator of cell growth that integrates growth factor signaling and nutrient availability and is a downstream effector of oncogenic receptor tyrosine kinases (RTK) and PI3K/Akt signaling. Thus, activating mTOR mutations would be expected to enhance growth in many tumor types. However, tumor sequencing data have shown that mTOR mutations are enriched only in renal clear cell carcinoma, a clinically hypervascular tumor unlikely to be constrained by nutrient availability. To further define this cancer-type–specific restriction, we studied activating mutations in mTOR. All mTOR mutants tested enhanced growth in a cell-type agnostic manner under nutrient-replete conditions but were detrimental to cell survival in nutrient-poor conditions. Consistently, analysis of tumor data demonstrated that oncogenic mutations in the nutrient-sensing arm of the mTOR pathway display a similar phenotype and were exceedingly rare in human cancers of all types. Together, these data suggest that maintaining the ability to turn off mTOR signaling in response to changing nutrient availability is retained in most naturally occurring tumors.Significance:This study suggests that cells need to inactivate mTOR to survive nutrient stress, which could explain the rarity of mTOR mutations and the limited clinical activity of mTOR inhibitors in cancer.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Supplementary Figure from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Supplementary Figure from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Supplementary Figure from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Supplementary Figure from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Supplementary Figure from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Supplementary Figure from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Supplementary Data from Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions